A detailed history of Fort Sheridan Advisors LLC transactions in Organon & Co. stock. As of the latest transaction made, Fort Sheridan Advisors LLC holds 10,093 shares of OGN stock, worth $204,988. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,093
Holding current value
$204,988
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $139,081 - $189,748
10,093 New
10,093 $189,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.17B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Fort Sheridan Advisors LLC Portfolio

Follow Fort Sheridan Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Sheridan Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Sheridan Advisors LLC with notifications on news.